Skip to content

The Effect of Art Therapy on Physical and Psychological Symptoms of Breast Cancer Survivors

The Effect of Group Art Therapy on Physical and Psychological Symptoms of Breast Cancer Survivors Receiving Hormonal Therapy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02982421
Enrollment
20
Registered
2016-12-05
Start date
2016-12-31
Completion date
2017-06-30
Last updated
2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Art Therapy is a health profession in which art making is utilized as a means of expression and communication within a therapeutic and supportive relationship \[1\]. Art therapy has been shown to reduce psychological (anxiety, negative mood) and physical (pain, fatigue) symptoms which accompany many breast cancer patients and survivors \[2-7\]. Qualitative studies provide an initial understanding of the mechanisms through which art therapy facilitates symptom reduction \[8\]. Breast cancer patients have reported that art therapy provided them with access to emotional material otherwise inaccessible \[9\]. The goal of this study is to examine the effect of art making within a therapeutic framework on emotional awareness and acceptance.

Interventions

Participants will engage in an art therapy group tailored at emotion expression related to the experience of breast cancer survivorship.

BEHAVIORALControl

Participants will receive Psychoeducational material in the form of a lecture and will engage in the coloring of mandalas.

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adult women (over age 18), breast cancer survivors without evidence of active illness, hebrew speaking and receiving preventative hormonal therapy for at least 6 months (steady state), receiving care at the survivor's clinic of Davidoff Medical Center

Exclusion criteria

A psychiatric diagnosis requiring medication, functional difficulties that affect the ability to handle art supplies, non-hebrew speaking, unwilling to answer the research questionnaires

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life: The FACT-B (Hahn et al, 2015)Change from study start to end of intervention (8 weeks)36 item scale

Secondary

MeasureTime frameDescription
Acceptance of Emotion Scale (AE; Weihs et al, 2008)Change from study start to end of intervention (8 weeks)13 item scale
Emotional Approach Coping scales (Stanton et al., 2000)Change from study start to end of intervention (8 weeks)36 item scale
The Mindful Attention Awareness Scale (MAAS)(Carlson & Brown, 2005).Change from study start to end of intervention (8 weeks)15 item scale
The levels of Emotional Awareness Scale (LEAS; Lane et al, 1990)Change from study start to end of intervention (8 weeks)20 item scale
The Generalized Anxiety Disorder scale (GAD-7) (Spitzer, Kroenke, Williams, & Löwe, 2006)Change from study start to end of intervention (8 weeks)7 item scale
The Breast Cancer Prevention Trial (BCPT) Symptom Scales (Stanton et al., 2005)Change from study start to end of intervention (8 weeks)23 item scale
Center for Epidemiologic Studies Depression Scale (CES-D) (Cohen, 1997)Change from study start to end of intervention (8 weeks)20 item scale

Countries

Israel

Contacts

Primary ContactJohanna Czamanski-Cohen, PhD
joczamanski@gmail.com+972532775350

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026